Risk factors for valproic acid resistance in childhood absence epilepsy

Seizure

Volumn 18, Issue 10, 2009, Pages 690-694

  Ollivier, May Lissa ^a   Dubois, Marie France ^b   Krajinovic, Maja ^c   Cossette, Patrick ^d   Carmant, Lionel ^a  

^a UNIVERSITY OF MONTREAL   (Canada)

^b CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^c UNIVERSITÉ DE MONTRÉAL   (Canada)

^d CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

Anticonvulsants; Co morbidity; Pharmacoresistance; Refractory seizures

Indexed keywords

ACETAZOLAMIDE; ANTICONVULSIVE AGENT; CARBAMAZEPINE; CLOBAZAM; CLONAZEPAM; ETHOSUXIMIDE; ETIRACETAM; LAMOTRIGINE; NITRAZEPAM; OXCARBAZEPINE; PREGABALIN; TOPIRAMATE; VALPROATE SEMISODIUM; VALPROIC ACID; VIGABATRIN; ZONISAMIDE;

ADOLESCENT; ARTICLE; CHILD; CHILDHOOD ABSENCE EPILEPSY; DEMOGRAPHY; DISEASE CONTROL; DRUG SUBSTITUTION; ELECTROENCEPHALOGRAPHY; EPILEPSY; FEMALE; HUMAN; IMAGING; INFANT; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; PHENOTYPE; PRESCHOOL CHILD; PRIORITY JOURNAL; RETROSPECTIVE STUDY; RISK FACTOR; SCHOOL CHILD; TONIC CLONIC SEIZURE; TREATMENT OUTCOME; TREATMENT RESPONSE;

ADOLESCENT; AGE OF ONSET; ANTICONVULSANTS; CHILD; CHILD, PRESCHOOL; ELECTROENCEPHALOGRAPHY; EPILEPSY, ABSENCE; FEMALE; HUMANS; INFANT; LONGITUDINAL STUDIES; MALE; PREDICTIVE VALUE OF TESTS; RISK FACTORS; TREATMENT OUTCOME; VALPROIC ACID;

EID: 71549149020     PISSN: 10591311     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.seizure.2009.09.007     Document Type: Article

References (25)

1. Kwan P., and Brodie M.J. Early identification of refractory epilepsy. N Engl J Med 342 (2000) 314-319
2. Brodie M.J. Diagnosing and predicting refractory epilepsy. Acta Neurol Scand Suppl 181 (2005) 36-39
3. Sillanpaa M., and Schmidt D. Natural history of treated childhood-onset epilepsy: prospective, long-term population-based study. Brain 129 (2006) 617-624
4. Camfield P.R., Camfield C.S., Gordon K., and Dooley J.M. If a first antiepileptic drug fails to control a child's epilepsy, what are the chances of success with the next drug?. J Pediatr 131 (1997) 821-824
5. Wirrell E., Camfield C., Camfield P., and Dooley J. Prognostic significance of failure of the initial antiepileptic drug in children with absence epilepsy. Epilepsia 42 (2001) 760-763
6. Berg A.T., Shinnar S., Levy S.R., Testa F.M., Smith-Rapaport S., and Beckerman B. Early development of intractable epilepsy in children: a prospective study. Neurology 56 (2001) 1445-1452
7. Kwong K.L., Sung W.Y., Wong S.N., and So K.T. Early predictors of medical intractability in childhood epilepsy. Pediatr Neurol 29 (2003) 46-52
8. Wolf P., and Inoue Y. Therapeutic response of absence seizures in patients of an epilepsy clinic for adolescents and adults. J Neurol 231 (1984) 225-229
9. Ko T.S., and Holmes G.L. EEG and clinical predictors of medically intractable childhood epilepsy. Clin Neurophysiol 110 (1999) 1245-1251
10. Hauser W.A. The prevalence and incidence of convulsive disorders in children. Epilepsia 35 Suppl. 2 (1994) S1-S6
11. Loiseau P., Duche B., and Pedespan J.M. Absence epilepsies. Epilepsia 36 (1995) 1182-1186
12. Duncan J.S. Idiopathic generalized epilepsies with typical absences. J Neurol 244 (1997) 403-411
13. Crunelli V., and Leresche N. Childhood absence epilepsy: genes, channels, neurons and networks. Nat Rev Neurosci 3 (2002) 371-382
14. Steriade M., and Amzica F. Sleep oscillations developing into seizures in corticothalamic systems. Epilepsia 44 Suppl. 12 (2003) 9-20
15. Steriade M. Sleep epilepsy and thalamic reticular inhibitory neurons. Trends Neurosci 28 (2005) 317-324
16. Brodie M.J., and Dichter M.A. Antiepileptic drugs. N Engl J Med 334 (1996) 168-175
17. Perucca E. The management of refractory idiopathic epilepsies. Epilepsia 42 Suppl. 3 (2001) 31-35
18. Glauser T., Ben-Menachem E., Bourgeois B., Cnaan A., Chadwick D., Guerreiro C., et al. ILAE treatment guidelines: evidence-based analysis of antiepileptic drug efficacy and effectiveness as initial monotherapy for epileptic seizures and syndromes. Epilepsia 47 (2006) 1094-1120
19. Sillanpaa M. Remission of seizures and predictors of intractability in long-term follow-up. Epilepsia 34 (1993) 930-936
20. ILAE. Proposal for revised classification of epilepsies and epileptic syndromes. Commission on Classification and Terminology of the International League Against Epilepsy. Epilepsia 30 (1989) 389-399
21. Collaborative Group for the Study of Epilepsy. Prognosis of epilepsy in newly referred patients: a multicenter prospective study of the effects of monotherapy on the long-term course of epilepsy. Epilepsia 33 (1992) 45-51
22. Dlugos D.J., Sammel M.D., Strom B.L., and Farrar J.T. Response to first drug trial predicts outcome in childhood temporal lobe epilepsy. Neurology 57 (2001) 2259-2264
23. Lynch M.W., Rutecki P.A., and Sutula T.P. The effects of seizures on the brain. Curr Opin Neurol 9 (1996) 97-102
24. Prevost J., Lortie A., Nguyen D., Lassonde M., and Carmant L. Nonlesional frontal lobe epilepsy (FLE) of childhood: clinical presentation, response to treatment and comorbidity. Epilepsia 47 (2006) 2198-2201
25. Bjornsson T.D., Wagner J.A., Donahue S.R., Harper D., Karim A., Khouri M.S., et al. A review and assessment of potential sources of ethnic differences in drug responsiveness. J Clin Pharmacol 43 (2003) 943-967